IP Library Granted Patent US 8,287,952
Granted Patent B2
US 8,287,952 · App. 11/036,752 · Granted Oct 16, 2012

Colloidal core-shell assemblies and methods of preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,287,952
App. No.
11/036,752
Granted
Oct 16, 2012
Kind
B2
Abstract

This invention relates to a method of making a composition comprising a colloid comprising particles having a colloidal silica core and a shell, said method comprising the steps of: simultaneously introducing into a vessel a first liquid stream containing silica core particles, a second liquid stream containing a polymer having amine functionalities; and a third liquid stream having a pH adjusting substance such that said vessel is maintained at a pH below 6.0, and followed by readjusting the pH of the colloid to a pH between about 7-10; the addition of a cross-linking reagent, and adjusting the pH of the colloid to approximately physiological conditions, wherein the core-shell colloid contains between 10 and 30 μmol amine-monomer/m 2 core surface area.

Claims (14)

1. A method of making a composition comprising a colloid which is stable under physiological pH and ionic strength, said colloid comprising particles having a colloidal silica core and a shell, said method comprising the steps of:

introducing into a vessel a first liquid stream containing core particles; simultaneously introducing into said vessel a second liquid stream containing a polymer made from a monomer having amine functionalities in an amount at least equal to the amount required to cover the surfaces of the core particles; and

simultaneously introducing into said vessel a third liquid stream having a pH adjusting substance at such a rate that the pH in said vessel is maintained at a pH below 6.0, and

subsequently readjusting the pH of the core-shell colloid to a pH between about 7-10; followed by the addition of a cross-linking reagent capable of cross-linking the polymer; and finally adjusting the pH of the colloid to approximately physiological conditions wherein the core-shell colloid contains between 10 and 30 μmol amine-monomer/m 2 core surface area.

2. The method of claim 1 wherein said polymer made from said monomer having amine functionalities comprises poly(ethylene)imine.

3. The method of claim 1 wherein the physiological conditions are pH 7.4 in 137 mM NaCl.

4. The method of claim 1 wherein the average particle size diameter of said core particles is between 1 and 500 nm.

5. The method of claim 1 wherein said polymer made from said monomer having amine functionalities is selected from the group consisting of poly(ethylene)imine, polyallylamine, chitosan, gelatin, amino-dextran, proteins, polypeptides and polylysine.

6. The method of claim 1 wherein said core-shell colloid is stable in salt solution having a concentration between about 30 mM to about 600 mM.

7. The method of claim 1 wherein greater than 70% of said polymer made from said monomer having amine functionalities is bound to said core.

8. The method of claim 1 wherein the core-shell colloid contains between 300 and 6000 μmol amine-monomer/g core particles.

9. The method of claim 1 wherein the average particle size diameter of said core particles is between 10 and 100 nm.

10. The method of claim 1 wherein said first, second and third liquid streams are brought together in a high shear mixing zone within a dispersion medium.

11. The method of claim 10 wherein said high shear mixing zone has a turnover rate of greater than 0.1 turnovers/sec.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
Reel/Frame 061681/0380 →